A Study YL201 in Patients With Selected Advanced Solid Tumors

Clinical trial NCT06057922 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06057922
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-09-22
Primary completion: 2026-10-01
Enrollment: 990

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.